Neuromuscular Disorders in Pregnancy

Abstract

Neuromuscular disorders may present and progress differently in women than in men. During pregnancy, medication adjustment, hormonal effects, and other alterations in physiology may influence the manifestation of a variety of neuromuscular disorders. The expression of existing conditions may change; previously asymptomatic conditions may be unmasked, or entirely new conditions may develop. Additionally, neuromuscular disorders and their treatments may have implications for the fetus. Such factors must be carefully considered when counseling and treating pregnant women and those considering pregnancy. This article reviews considerations specific to women and issues surrounding pregnancy in disorders of the neuromuscular junction, focal neuropathies, and acquired and inherited disorders of the nerve and muscle.

Keywords

neuromuscular disease - pregnancy - myasthenia gravis - neuropathy - myopathy

• References

• 1 Amato AA, Russell JA. Neuromuscular Disorders. 2nd ed. Boston: McGraw-Hill Education Medical; 2016
• 2 Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37 (02) 141-149
• 3 Sanders DB, Wolfe GI, Benatar M. , et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 2016; 87 (04) 419-425
• 4 Mays J, Butts CL. Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis. Neuroimmunomodulation 2011; 18 (05) 320-327
• 5 Leker RR, Karni A, Abramsky O. Exacerbation of myasthenia gravis during the menstrual period. J Neurol Sci 1998; 156 (01) 107-111
• 6 Frenkel M. Treatment of myasthenia gravis by ovulatory suppression. Arch Neurol 1964; 11: 613-617
• 7 Stickler DE, Stickler LL. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis. Muscle Nerve 2007; 35 (06) 808-811
• 8 Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002; 104 (01) 21-25
• 9 Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guéry JC. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J Immunol 2005; 175 (08) 5050-5057
• 10 Wu KH, Tobias ML, Kelley DB. Estrogen and laryngeal synaptic strength in Xenopus laevis: opposite effects of acute and chronic exposure. Neuroendocrinology 2001; 74 (01) 22-32
• 11 Wargon I, Richard P, Kuntzer T. , et al. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations. Neuromuscul Disord 2012; 22 (04) 318-324
• 12 Servais L, Baudoin H, Zehrouni K. , et al. Pregnancy in congenital myasthenic syndrome. J Neurol 2013; 260 (03) 815-819
• 13 Wakata N, Nemoto H, Sugimoto H. , et al. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 2004; 106 (02) 139-141
• 14 Pouwels S, de Boer A, Javaid MK. , et al. Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int 2013; 24 (02) 467-476
• 15 Yeh JH, Chen HJ, Chen YK, Chiu HC, Kao CH. Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study. Neurology 2014; 83 (12) 1075-1079
• 16 Grossman JM, Gordon R, Ranganath VK. , et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62 (11) 1515-1526
• 17 Attar SM. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. A hospital-based study. Saudi Med J 2010; 31 (08) 909-915
• 18 Sonthalia S, Daulatabad D. Azathioprine-associated anagen effluvium. Indian J Dermatol Venereol Leprol 2016; 82 (03) 322-324
• 19 Norwood F, Dhanjal M, Hill M. , et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry 2014; 85 (05) 538-543
• 20 Ohlraun S, Hoffmann S, Klehmet J. , et al. Impact of myasthenia gravis on family planning: How do women with myasthenia gravis decide and why?. Muscle Nerve 2015; 52 (03) 371-379
• 21 Ciafaloni E, Massey JM. Myasthenia gravis and pregnancy. Neurol Clin 2004; 22 (04) 771-782
• 22 Massey JM, De Jesus-Acosta C. Pregnancy and myasthenia gravis. Continuum (Minneap Minn) 2014; 20 (1 Neurology of Pregnancy): 115-127
• 23 Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52 (03) 447-452
• 24 Braga AC, Pinto C, Santos E, Braga J. Myasthenia gravis in pregnancy: experience of a Portuguese center. Muscle Nerve 2016; 54 (04) 715-720
• 25 Ducci RD, Lorenzoni PJ, Kay CS, Werneck LC, Scola RH. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord 2017; 27 (04) 352-357
• 26 Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. ; National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197 (06) 585.e1-585.e7 , discussion 683–684, e1–e7
• 27 Park-Wyllie L, Mazzotta P, Pastuszak A. , et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62 (06) 385-392
• 28 Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 2011; 183 (07) 796-804
• 29 Skuladottir H, Wilcox AJ, Ma C. , et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol 2014; 100 (06) 499-506
• 30 Guidon AC, Massey EW. Neuromuscular disorders in pregnancy. Neurol Clin 2012; 30 (03) 889-911
• 31 Clark AL. Clinical uses of intravenous immunoglobulin in pregnancy. Clin Obstet Gynecol 1999; 42 (02) 368-380
• 32 Wolfe GI, Kaminski HJ, Cutter GR. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 2016; 375 (20) 2006-2007
• 33 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (03) 130-137
• 34 Haider B, von Oertzen J. Neurological disorders. Best Pract Res Clin Obstet Gynaecol 2013; 27 (06) 867-875
• 35 Ozcan J, Balson IF, Dennis AT. New diagnosis myasthenia gravis and preeclampsia in late pregnancy. BMJ Case Rep 2015; 2015: bcr2014208323 . Doi: 10.1136/bcr-2014-208323
• 36 Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 2007; 14 (01) 38-43
• 37 O'carroll P, Bertorini TE, Jacob G, Mitchell CW, Graff J. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis. J Clin Neuromuscul Dis 2009; 11 (02) 69-71
• 38 Niks EH, Verrips A, Semmekrot BA. , et al. A transient neonatal myasthenic syndrome with anti-musk antibodies. Neurology 2008; 70 (14) 1215-1216
• 39 Townsel C, Keller R, Johnson K, Hussain N, Campbell WA. Seronegative maternal ocular myasthenia gravis and delayed transient neonatal myasthenia gravis. AJP Rep 2016; 6 (01) e133-e136
• 40 Ahlsten G, Lefvert AK, Osterman PO, Stålberg E, Säfwenberg J. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy. J Child Neurol 1992; 7 (03) 264-269
• 41 D'Amico A, Bertini E, Bianco F. , et al. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report. Neuromuscul Disord 2012; 22 (06) 546-548
• 42 Hacohen Y, Jacobson LW, Byrne S. , et al. Fetal acetylcholine receptor inactivation syndrome: A myopathy due to maternal antibodies. Neurol Neuroimmunol Neuroinflamm 2014; 2 (01) e57
• 43 Oskoui M, Jacobson L, Chung WK. , et al. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis. Neurology 2008; 71 (24) 2010-2012
• 44 Katz A, Sergienko R, Dior U, Wiznitzer A, Kaplan DM, Sheiner E. Bell's palsy during pregnancy: is it associated with adverse perinatal outcome?. Laryngoscope 2011; 121 (07) 1395-1398
• 45 Phillips KM, Heiser A, Gaudin R, Hadlock TA, Jowett N. Onset of Bell's palsy in late pregnancy and early puerperium is associated with worse long-term outcomes. Laryngoscope 2017; 127 (12) 2854-2859
• 46 Vrabec JT, Isaacson B, Van Hook JW. Bell's palsy and pregnancy. Otolaryngol Head Neck Surg 2007; 137 (06) 858-861
• 47 Monini S, Lazzarino AI, Iacolucci C, Buffoni A, Barbara M. Epidemiology of Bell's palsy in an Italian Health District: incidence and case-control study. Acta Otorhinolaryngol Ital 2010; 30 (04) 198-204
• 48 Shmorgun D, Chan WS, Ray JG. Association between Bell's palsy in pregnancy and pre-eclampsia. QJM 2002; 95 (06) 359-362
• 49 Gronseth GS, Paduga R. ; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012; 79 (22) 2209-2213
• 50 Gillman GS, Schaitkin BM, May M, Klein SR. Bell's palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126 (01) 26-30
• 51 Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 2010; 304 (08) 859-866
• 52 Padua L, Di Pasquale A, Pazzaglia C, Liotta GA, Librante A, Mondelli M. Systematic review of pregnancy-related carpal tunnel syndrome. Muscle Nerve 2010; 42 (05) 697-702
• 53 Mondelli M, Rossi S, Monti E. , et al. Prospective study of positive factors for improvement of carpal tunnel syndrome in pregnant women. Muscle Nerve 2007; 36 (06) 778-783
• 54 Stolp-Smith KA, Pascoe MK, Ogburn Jr PL. Carpal tunnel syndrome in pregnancy: frequency, severity, and prognosis. Arch Phys Med Rehabil 1998; 79 (10) 1285-1287
• 55 Moghtaderi AR, Moghtaderi N, Loghmani A. Evaluating the effectiveness of local dexamethasone injection in pregnant women with carpal tunnel syndrome. J Res Med Sci 2011; 16 (05) 687-690
• 56 Skeen MB, Eggleston M. Thoraconeuralgia gravidarum. Muscle Nerve 1999; 22 (06) 779-780
• 57 Pleet AB, Massey EW. Intercostal neuralgia of pregnancy. JAMA 1980; 243 (08) 770
• 58 Lederman RJ, Wilbourn AJ. Postpartum neuralgic amyotrophy. Neurology 1996; 47 (05) 1213-1219
• 59 van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006; 129 (Pt 2): 438-450
• 60 Roubal PJ, Chavinson AH, LaGrandeur RM. Bilateral radial nerve palsies from use of the standard birthing bar. Obstet Gynecol 1996; 87 (5 Pt 2): 820-821
• 61 Richard A, Vellieux G, Abbou S, Benifla JL, Lozeron P, Kubis N. Good prognosis of postpartum lower limb sensorimotor deficit: a combined clinical, electrophysiological, and radiological follow-up. J Neurol 2017; 264 (03) 529-540
• 62 Wong CA, Scavone BM, Dugan S. , et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101 (02) 279-288
• 63 Klein A. Peripheral nerve disease in pregnancy. Clin Obstet Gynecol 2013; 56 (02) 382-388
• 64 Amundsen S, Nordeng H, Nezvalová-Henriksen K, Stovner LJ, Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol 2015; 11 (04) 209-219
• 65 LaBan MM, Rapp NS, von Oeyen P, Meerschaert JR. The lumbar herniated disk of pregnancy: a report of six cases identified by magnetic resonance imaging. Arch Phys Med Rehabil 1995; 76 (05) 476-479
• 66 Ardaillon H, Laviv Y, Arle JE, Kasper EM. Lumbar disk herniation during pregnancy: a review on general management and timing of surgery. Acta Neurochir (Wien) 2017; (e-pub ahead of print)
• 67 Cheng Q, Jiang GX, Fredrikson S, Link H, de Pedro-Cuesta J. Increased incidence of Guillain–Barré syndrome postpartum. Epidemiology 1998; 9 (06) 601-604
• 68 Lupo J, Germi R, Jean D. , et al. Guillain–Barré syndrome and cytomegalovirus infection during pregnancy. J Clin Virol 2016; 79: 74-76
• 69 Pollak-Christian E, Lee KS. Importance of diagnostic work-up of Guillain–Barré syndrome in pregnancy. BMJ Case Rep 2016;
• 70 Krauer F, Riesen M, Reveiz L. , et al; WHO Zika Causality Working Group. Zika virus infection as a cause of congenital brain abnormalities and Guillain–Barré syndrome: systematic review. PLoS Med 2017; 14 (01) e1002203
• 71 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014; : CD002063
• 72 Chan LY, Tsui MH, Leung TN. Guillain–Barré syndrome in pregnancy. Acta Obstet Gynecol Scand 2004; 83 (04) 319-325
• 73 Ioannides ZA, Airey C, Fagermo N, Blum S, McCombe PA, Henderson RD. Susac syndrome and multifocal motor neuropathy first manifesting in pregnancy. Aust N Z J Obstet Gynaecol 2013; 53 (03) 314-317
• 74 Chaudhry V, Escolar DM, Cornblath DR. Worsening of multifocal motor neuropathy during pregnancy. Neurology 2002; 59 (01) 139-141
• 75 McCombe PA, McManis PG, Frith JA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy associated with pregnancy. Ann Neurol 1987; 21 (01) 102-104
• 76 Rudnik-Schöneborn S, Röhrig D, Nicholson G, Zerres K. Pregnancy and delivery in Charcot–Marie–Tooth disease type 1. Neurology 1993; 43 (10) 2011-2016
• 77 Awater C, Zerres K, Rudnik-Schöneborn S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol 2012; 162 (02) 153-159
• 78 Hoff JM, Gilhus NE, Daltveit AK. Pregnancies and deliveries in patients with Charcot–Marie–Tooth disease. Neurology 2005; 64 (03) 459-462
• 79 Rudnik-Schöneborn S, Zerres K, Ignatius J, Rietschel M. Pregnancy and spinal muscular atrophy. J Neurol 1992; 239 (01) 26-30
• 80 Hopkins AN, Alshaeri T, Akst SA, Berger JS. Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist. Semin Perinatol 2014; 38 (06) 359-369
• 81 Flunt D, Andreadis N, Menadue C, Welsh AW. Clinical commentary: obstetric and respiratory management of pregnancy with severe spinal muscular atrophy. Obstet Gynecol Int 2009;
• 82 Finkel RS, Chiriboga CA, Vajsar J. , et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 2016; 388 (10063): 3017-3026
• 83 Sax TW, Rosenbaum RB. Neuromuscular disorders in pregnancy. Muscle Nerve 2006; 34 (05) 559-571
• 84 Lunetta C, Sansone VA, Penco S. , et al. Amyotrophic lateral sclerosis in pregnancy is associated with a vascular endothelial growth factor promoter genotype. Eur J Neurol 2014; 21 (04) 594-598
• 85 Xiao W, Zhao L, Wang F, Sun H, Wang T, Zhao G. Total intravenous anesthesia without muscle relaxant in a parturient with amyotrophic lateral sclerosis undergoing cesarean section: a case report. J Clin Anesth 2017; 36: 107-109
• 86 Rudnik-Schöneborn S, Zerres K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004; 114 (01) 44-53
• 87 Johnson NE, Hung M, Nasser E. , et al. The impact of pregnancy on myotonic dystrophy: a registry-based study. J Neuromuscul Dis 2015; 2 (04) 447-452
• 88 Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007; 29 (03) 284-288
• 89 Erikson A, Forsberg H, Drugge U, Holmgren G. Outcome of pregnancy in women with myotonic dystrophy and analysis of CTG gene expansion. Acta Paediatr 1995; 84 (04) 416-418
• 90 Rudnik-Schöneborn S, Schneider-Gold C, Raabe U, Kress W, Zerres K, Schoser BG. Outcome and effect of pregnancy in myotonic dystrophy type 2. Neurology 2006; 66 (04) 579-580
• 91 Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Bégin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997; 49 (06) 1646-1650
• 92 Kakourou G, Dhanjal S, Mamas T. , et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1 in the UK. Neuromuscul Disord 2008; 18 (02) 131-136
• 93 Feyereisen E, Amar A, Kerbrat V. , et al. Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?. Hum Reprod 2006; 21 (01) 175-182
• 94 Verpoest W, De Rademaeker M, Sermon K. , et al. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod 2008; 23 (07) 1654-1660
• 95 Lacomis D, Gonzales JT, Giuliani MJ. Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies. Clin Neurol Neurosurg 1999; 101 (02) 133-136
• 96 Basu A, Nishanth P, Ifaturoti O. Pregnancy in women with myotonia congenita. Int J Gynaecol Obstet 2009; 106 (01) 62-63
• 97 Gorthi S, Radbourne S, Drury N, Rajagopalan C. Management of pregnancy with Thomsen's disease. Eur J Obstet Gynecol Reprod Biol 2013; 170 (01) 293-294
• 98 Rudnik-Schöneborn S, Witsch-Baumgartner M, Zerres K. Influences of pregnancy on different genetic subtypes of non-dystrophic myotonia and periodic paralysis. Gynecol Obstet Invest 2016; 81 (05) 472-476
• 99 Burge JA, Hanna MG, Schorge S. Nongenomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle. Muscle Nerve 2013; 48 (04) 589-591
• 100 Ciafaloni E, Pressman EK, Loi AM. , et al. Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology 2006; 67 (10) 1887-1889
• 101 Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003; 349 (26) 2503-2509
• 102 Findlay S, Liu D, Rijhsinghani A. Acute compartment syndrome: clinical course and laboratory findings in pregnant patients with McArdle's disease. Pain Med 2014; 15 (03) 481-482
• 103 Giles W, Maher C. Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome. Obstet Med 2011; 4 (03) 120-121
• 104 Kłos J, Kwaśniak-Butowska M, Sławek J. Alglucosidase alfa therapy for Pompe disease in pregnancy – case report. J Neurol Sci 2017; 375: 167-169
• 105 de Vries JM, Brugma JD, Ozkan L. , et al. First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease. Mol Genet Metab 2011; 104 (04) 552-555
• 106 Zagnoli F, Leblanc A, Blanchard C. Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiency. Neuromuscul Disord 2013; 23 (02) 180-181
• 107 Sánchez MV, Romero R. Acute pulmonary edema secondary to pregnancy in a patient with the mitochondrial disease MELAS. Rev Esp Cardiol 2010; 63 (05) 615-617
• 108 Yanagawa T, Sakaguchi H, Nakao T. , et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with deterioration during pregnancy. Intern Med 1998; 37 (09) 780-783
• 109 de Laat P, Fleuren LH, Bekker MN, Smeitink JA, Janssen MC. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion 2015; 25: 98-103
• 110 Maurtua M, Torres A, Ibarra V, DeBoer G, Dolak J. Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review. Int J Obstet Anesth 2008; 17 (04) 370-373
• 111 Pinheiro GdaR, Goldenberg J, Atra E, Pereira RB, Camano L, Schmidt B. Juvenile dermatomyositis and pregnancy: report and literature review. J Rheumatol 1992; 19 (11) 1798-1801
• 112 Pinal-Fernandez I, Selva-O'Callaghan A, Fernandez-Codina A. , et al. “Pregnancy in adult-onset idiopathic inflammatory myopathy”: report from a cohort of myositis patients from a single center. Semin Arthritis Rheum 2014; 44 (02) 234-240
• 113 Váncsa A, Ponyi A, Constantin T, Zeher M, Dankó K. Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int 2007; 27 (05) 435-439
• 114 Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2003; 42 (10) 1168-1172
• 115 Zhong Z, Lin F, Yang J, Zhang F, Zeng X, You X. Pregnancy in polymyositis or dermatomyositis: retrospective results from a tertiary centre in China. Rheumatology (Oxford) 2017; 56 (08) 1272-1275
• 116 Akalin T, Akkaya H, Büke B, Koçak İ. A case of new-onset dermatomyositis in the second trimester of pregnancy: a case report and review of the literature. Case Rep Obstet Gynecol 2016; 2016: 6430156
• 117 Linardaki G, Cherouvim E, Goni G, Boki KA. Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis. Rheumatol Int 2011; 31 (01) 113-115
• 118 Nozaki Y, Ikoma S, Funauchi M, Kinoshita K. Respiratory muscle weakness with dermatomyositis during pregnancy: successful treatment with intravenous immunoglobulin therapy. J Rheumatol 2008; 35 (11) 2289
• 119 Norwood F, Rudnik-Schöneborn S. 179th ENMC international workshop: pregnancy in women with neuromuscular disorders 5–7 November 2010, Naarden, The Netherlands. Neuromuscul Disord 2012; 22 (02) 183-190